The FDA has approved Pfizer‘s IBRANCE (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of HR+/HER2+ locally…
THE UK GOVERNMENT has set out details of announcements on leveraging AI, spanning investment and workforce transformation, at London Tech Week 2026 in June. The…
By Jane Lewis, chief operating officer, chief financial officer and women’s health lead, ABHI For years, the conversation around women’s health has rightly focused on…
Image: Conceivable IVI RMA Global, a leading fertility care organization, and Conceivable Life Sciences have announced a strategic partnership – including an investment by IVI…
